The somatic evolution of cancer: The Harveian Oration of 1996

Journal of the Royal College of Physicians of London

Volumn 31, Issue 1, 1997, Pages 82-89

  Bodmer, Walter ^b  

^a HERTFORD COLLEGE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; CANCER; CARCINOGENESIS; CELL DIVISION; CHROMOSOME; DISEASE COURSE; GENETICS; HEALTH CARE COST; HUMAN; REVIEW;

ADENOMATOUS POLYPOSIS COLI; CELL DEATH; CELL DIVISION; HUMANS; NEOPLASMS;

EID: 0031027433     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Virchow R. Die Cellular Pathologie in ihre Begrundung auf physiologische und pathologische Gewebelhre. Berlin: Hirschwald,1858.
2. Boveri T. Zur Frage der Entstehungmaligner Tumoren. Jena: Gustav Fischer, 1914.
3. Tyzzer EE. Tumor immunity. J Cancer Research 1916;i:125-55.
4. Nowell P, Hungerford DA. A minute chromosome in human chronic granulocytic leukaemia. Science 1960;132:1197.
5. Rowley JD. Chromosome abnormalities in human leukemia. Annu Rev Genet 1980;14:17-39.
6. Franks LM, Teich NM. Introduction to the cellular and molecular biology of cancer. (Second edition). Oxford: Oxford University Press, 1991.
7. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:82-3.
8. Weatherall D. The role of nature and nurture in common diseases: Garrod's Legacy. (Harveian Oration). London: Royal College of Physicians, 1992.
9. Herrera L, Kakati S, Gibas L, Pietrzak E, Sandbert AA, et al. Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 1986;25:473-6.
10. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJ, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328:614-6.
11. Groden J, Thliveris A, Samowitz W, Carlson M, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
12. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-5.
13. Bodmer WF. Cancer Genetics. Br Med Bull 1994;50:517-26.
14. Nugent KP, Phillips RKS, Hodgson SV, Cottrell S, et al. Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis. Gut 1994;35:1622-3.
15. Harris CC. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science 1993;262:1980-1.
16. Peifer M. Regulating cell proliferation: as easy as APC. Science 1996;272:974-5.
17. Novelli MR, Williamson JA, Tomlinson IP, Elia G, et al. Polyclonal origin of colonie adenomas in an XO/XY patient with FAP. Science 1996;272:1187-90.
18. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990;247:322-4.
19. Armitage P, Doll R. The age distribution of cancer and a multistage theory of carcinogenesis. Br J Cancer 1954;8:1-12.
20. Tomlinson IPM, Novelli MR, Bodmer WF. The mutation rate and cancer. Proc Natl Acad Sci USA (in press).
21. Lane DP. p53 and human cancers. Br Med Bull 1994;50:582-89.
22. Williams BO, Remington L, Albert DM, Mukai S, et al. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nature Genetics 1994;7:480-4.
23. Tomlinson IPM, Bodmer WF. Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models. Proc Natl Acad Sci USA 1995;92:11130-4.
24. Doll R, Peto R. The causes of cancer. Oxford: Oxford University Press, 1981.
25. Atkin WS, Cuzick J, Northover JMA, Whynes DK, et al. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993;341:736-40.